Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections
Microorganisms · 21.04.2025 · 13 (4) · 952
DOI: 10.3390/microorganisms13040952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 21.04.2025. Verfasst von Eudald Casals und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: international joint research projects program MCIN/AEI, European Union and Generalitat de Catalunya, Spanish MCIN/AEI.
Abstract (Originalsprache)
The escalating threat of antibiotic resistance demands innovative strategies against multidrug-resistant (MDR) microorganisms, particularly in hospital settings where such infections represent a major global health challenge. Since the rapid growth of nanotechnology interdisciplinary research and funding programs in the 2000s, silver ions have re-emerged as potent antimicrobial agents, offering a promising complement to conventional therapies. This therapeutic potential is nowadays explored through the use of silver nanoparticles (AgNPs) as sources for silver ions release. Recent studies have shown that controlled silver ion release enhances the efficacy of common antibiotics. This can be attributed to the energetically demanding nature of the bacterial response to silver, which weakens bacterial metabolism and, in turn, overwhelms bacterial defenses and increases antibiotic effectiveness. Herein, historical insights into the use of colloidal silver and AgNPs are combined with a review of recent research on the exploitation of the synergistic effect between AgNPs and antibiotics as a promising strategy against MDR pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
- Premium Research SL, 19003 Guadalajara, Spain.
- Catalan Institute of Nanoscience & Nanotechnology (ICN2), Consejo Superior de Investigaciones Científicas (CSIC), The Barcelona Institute of Science and Technology (BIST), Campus UAB, 08193 Bellaterra, Spain.
- Networking Research Centre for Bioengineering Biomaterials, and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain.
- CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Formation, Recherche, Evaluation (FOREVA) Research Unit, CHU Nîmes, 30029 Nîmes, France.
ORCID-Profile: Eudald Casals, Muriel F Gusta, Neus Bastus, Jordi Rello
Förderung
- international joint research projects program MCIN/AEI
- European Union and Generalitat de Catalunya
- Spanish MCIN/AEI
- CERCA Programme/Generalitat de Catalunya
Zitieren
APA
Casals, E., Gusta, M. F., Bastus, N., Rello, J., & Puntes, V. (2025). Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections. Microorganisms, 13(4), 952. https://doi.org/10.3390/microorganisms13040952
Vancouver
Casals E, Gusta MF, Bastus N, Rello J, Puntes V. Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections. Microorganisms. 2025;13(4):952. doi:10.3390/microorganisms13040952
BibTeX
@article{Casals2025,
author = {Casals, Eudald and Gusta, Muriel F and Bastus, Neus and Rello, Jordi and Puntes, Victor},
title = {Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {4},
pages = {952},
doi = {10.3390/microorganisms13040952}
}
EUVIMED